Emory University
Pediatric Hematology/Oncology Hospitalist Nocturnist
Emory University, Atlanta, Georgia, United States, 30383
Pediatric Hematology/Oncology Hospitalist Nocturnist
Overview
Emory University is a leading research university that fosters excellence and attracts world‑class talent to innovate today and prepare leaders for the future. We welcome candidates who can contribute to the excellence of our academic community.
Description The Aflac Cancer & Blood Disorders Center of Children’s Healthcare of Atlanta and the Emory University Department of Pediatrics invite interested applicants for a faculty level position in pediatric Hematology‑Oncology. The Aflac Cancer & Blood Disorders Center provides a rich and collaborative environment for basic, clinical, and translational research and boasts a diverse faculty. These physicians will care for hematology and oncology patients during the night, including patients receiving chemotherapy. Our nocturnists work collaboratively with residents and other specialists to admit children requiring hematology/oncology care, take nurse calls, and offer after‑hours expertise in managing the complex illnesses that children with cancer and blood disorders develop. Our nocturnists staff the Aflac Cancer and Blood Disorders Center inpatient units for 13 hours a day, seven days a week. This position will devote effort to inpatient clinical responsibilities from 6:30 PM to 7:30 AM for a total of 114 shifts/year. This position is located at Arthur M. Blank Hospital.
About The Aflac Cancer & Blood Disorders Center
In 2024, the Aflac Cancer & Blood Disorders Center was ranked No. 12 in the nation for Pediatric Cancer by U.S. News & World Report.
Each year our team cares for more than 170 newly diagnosed leukemia and lymphoma patients using a variety of treatment protocols, including blood and marrow transplant (BMT), hematopoietic stem cell transplant, chimeric antigen receptor (CAR)-T therapy, and Phase I and II clinical trials for patients whose cancer has relapsed or is not responding to treatment.
The Aflac Cancer & Blood Disorders Center has over 130 faculty and nearly 50 advanced practice providers (APPs), conducting basic, translational, cooperative group and investigator‑initiated clinical research related to pediatric oncology and hematology disorders, with expertise in leukemias, lymphomas, brain tumors, neuroblastoma, sarcomas, rare tumors, renal tumors, CAR‑T‑cell therapies, cancer survivorship, health services research, hemoglobinopathies and hemophilia.
More than 9,000 children with cancer and blood disorders are treated annually at the Aflac Cancer & Blood Disorders Center.
The Aflac pediatric oncology program sees approximately 500 new cancer diagnoses each year. Aflac is the pediatric component of the Winship Cancer Institute of Emory University.
The Aflac pediatric hematology program is one of the largest in the country (including >2,000 active patients with sickle cell disease, and >1,000 with bleeding or clotting disorders).
The Aflac blood and marrow transplantation program performs approximately 80 transplants each year, and is one of the leaders in curative therapies for hemoglobinopathies.
In 2024, Aflac faculty generated $31 M in extramural funding, including more than $17 M from the National Institutes of Health.
The Aflac fellowship program accepts six fellows each year for intensive clinical and research training in pediatric hematology/oncology. We are one of the few pediatric programs with an NIH‑funded T32 training grant in non‑malignant hematology.
The Aflac Developmental Therapeutics Program includes leukemia and lymphoma faculty from the high‑risk leukemia team and offers a wide portfolio of clinical trials from cooperative groups, industry partners, and investigator‑initiated studies, and has a larger referral base in the southeastern United States. Aflac is a member of the COG Pediatric Early Phase Clinical Trials Network (PEP‑CTN), NANT, TACL, and PBTC.
The MIBG and Relapsed Neuroblastoma Program is the largest in the southeast and has treated approximately 100 patients with therapeutic MIBG since its inception in 2013.
Successful Candidates Will Have
MD, DO, or PhD (MD/PhD) degrees.
Preference for Board Certification in Pediatric Hematology‑Oncology, but not required.
Must be eligible for licensure as a physician in the State of Georgia.
A history of clinical excellence and achievement.
Salary and Rank Salary and rank of Assistant Professor or Associate Professor at Emory University School of Medicine will be commensurate with experience and accomplishments. The primary focus of this position will be an emphasis on inpatient clinical service.
Additional Details Employment will be at the Emory + Children’s Pediatric Institute, an affiliation between Emory University and Children’s Healthcare of Atlanta. The position requires in‑person work at an Emory University location; remote work is not an option. Emory reserves the right to change this status with notice.
Equal Opportunity Statement Emory is an equal opportunity employer, and qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability, protected veteran status, or other characteristics protected by state or federal law. Emory University does not discriminate in admissions, educational programs, or employment, including recruitment, hiring, promotions, transfers, discipline, terminations, wage and salary administration, benefits, and training. Students, faculty, and staff are assured of participation in university programs and in the use of facilities without such discrimination. Emory University complies with Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veteran’s Readjustment Assistance Act, and applicable executive orders, federal and state regulations regarding nondiscrimination, equal opportunity, and affirmative action (for protected veterans and individuals with disabilities). Inquiries regarding this policy should be directed to the Emory University Department of Equity and Civil Rights Compliance, 201 Dowman Drive, Administration Building, Atlanta, GA 30322. Telephone: 404‑727‑9867 (V) | 404‑712‑2049 (TDD). Emory University is committed to ensuring equal access and providing reasonable accommodations to qualified individuals with disabilities upon request. To request this document in an alternate format or to seek a reasonable accommodation, please contact the Department of Accessibility Services at accessibility@emory.edu or call 404‑727‑9877 (Voice) | 404‑712‑2049 (TDD). We kindly ask that requests be made at least seven business days in advance to allow adequate time for coordination.
#J-18808-Ljbffr
Description The Aflac Cancer & Blood Disorders Center of Children’s Healthcare of Atlanta and the Emory University Department of Pediatrics invite interested applicants for a faculty level position in pediatric Hematology‑Oncology. The Aflac Cancer & Blood Disorders Center provides a rich and collaborative environment for basic, clinical, and translational research and boasts a diverse faculty. These physicians will care for hematology and oncology patients during the night, including patients receiving chemotherapy. Our nocturnists work collaboratively with residents and other specialists to admit children requiring hematology/oncology care, take nurse calls, and offer after‑hours expertise in managing the complex illnesses that children with cancer and blood disorders develop. Our nocturnists staff the Aflac Cancer and Blood Disorders Center inpatient units for 13 hours a day, seven days a week. This position will devote effort to inpatient clinical responsibilities from 6:30 PM to 7:30 AM for a total of 114 shifts/year. This position is located at Arthur M. Blank Hospital.
About The Aflac Cancer & Blood Disorders Center
In 2024, the Aflac Cancer & Blood Disorders Center was ranked No. 12 in the nation for Pediatric Cancer by U.S. News & World Report.
Each year our team cares for more than 170 newly diagnosed leukemia and lymphoma patients using a variety of treatment protocols, including blood and marrow transplant (BMT), hematopoietic stem cell transplant, chimeric antigen receptor (CAR)-T therapy, and Phase I and II clinical trials for patients whose cancer has relapsed or is not responding to treatment.
The Aflac Cancer & Blood Disorders Center has over 130 faculty and nearly 50 advanced practice providers (APPs), conducting basic, translational, cooperative group and investigator‑initiated clinical research related to pediatric oncology and hematology disorders, with expertise in leukemias, lymphomas, brain tumors, neuroblastoma, sarcomas, rare tumors, renal tumors, CAR‑T‑cell therapies, cancer survivorship, health services research, hemoglobinopathies and hemophilia.
More than 9,000 children with cancer and blood disorders are treated annually at the Aflac Cancer & Blood Disorders Center.
The Aflac pediatric oncology program sees approximately 500 new cancer diagnoses each year. Aflac is the pediatric component of the Winship Cancer Institute of Emory University.
The Aflac pediatric hematology program is one of the largest in the country (including >2,000 active patients with sickle cell disease, and >1,000 with bleeding or clotting disorders).
The Aflac blood and marrow transplantation program performs approximately 80 transplants each year, and is one of the leaders in curative therapies for hemoglobinopathies.
In 2024, Aflac faculty generated $31 M in extramural funding, including more than $17 M from the National Institutes of Health.
The Aflac fellowship program accepts six fellows each year for intensive clinical and research training in pediatric hematology/oncology. We are one of the few pediatric programs with an NIH‑funded T32 training grant in non‑malignant hematology.
The Aflac Developmental Therapeutics Program includes leukemia and lymphoma faculty from the high‑risk leukemia team and offers a wide portfolio of clinical trials from cooperative groups, industry partners, and investigator‑initiated studies, and has a larger referral base in the southeastern United States. Aflac is a member of the COG Pediatric Early Phase Clinical Trials Network (PEP‑CTN), NANT, TACL, and PBTC.
The MIBG and Relapsed Neuroblastoma Program is the largest in the southeast and has treated approximately 100 patients with therapeutic MIBG since its inception in 2013.
Successful Candidates Will Have
MD, DO, or PhD (MD/PhD) degrees.
Preference for Board Certification in Pediatric Hematology‑Oncology, but not required.
Must be eligible for licensure as a physician in the State of Georgia.
A history of clinical excellence and achievement.
Salary and Rank Salary and rank of Assistant Professor or Associate Professor at Emory University School of Medicine will be commensurate with experience and accomplishments. The primary focus of this position will be an emphasis on inpatient clinical service.
Additional Details Employment will be at the Emory + Children’s Pediatric Institute, an affiliation between Emory University and Children’s Healthcare of Atlanta. The position requires in‑person work at an Emory University location; remote work is not an option. Emory reserves the right to change this status with notice.
Equal Opportunity Statement Emory is an equal opportunity employer, and qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability, protected veteran status, or other characteristics protected by state or federal law. Emory University does not discriminate in admissions, educational programs, or employment, including recruitment, hiring, promotions, transfers, discipline, terminations, wage and salary administration, benefits, and training. Students, faculty, and staff are assured of participation in university programs and in the use of facilities without such discrimination. Emory University complies with Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veteran’s Readjustment Assistance Act, and applicable executive orders, federal and state regulations regarding nondiscrimination, equal opportunity, and affirmative action (for protected veterans and individuals with disabilities). Inquiries regarding this policy should be directed to the Emory University Department of Equity and Civil Rights Compliance, 201 Dowman Drive, Administration Building, Atlanta, GA 30322. Telephone: 404‑727‑9867 (V) | 404‑712‑2049 (TDD). Emory University is committed to ensuring equal access and providing reasonable accommodations to qualified individuals with disabilities upon request. To request this document in an alternate format or to seek a reasonable accommodation, please contact the Department of Accessibility Services at accessibility@emory.edu or call 404‑727‑9877 (Voice) | 404‑712‑2049 (TDD). We kindly ask that requests be made at least seven business days in advance to allow adequate time for coordination.
#J-18808-Ljbffr